• Something wrong with this record ?

Effects of metabolic syndrome on arterial function in different age groups: the Advanced Approach to Arterial Stiffness study

J. Topouchian, C. Labat, S. Gautier, M. Bäck, A. Achimastos, J. Blacher, M. Cwynar, A. de la Sierra, D. Pall, F. Fantin, K. Farkas, L. Garcia-Ortiz, Z. Hakobyan, P. Jankowski, A. Jelakovic, Z. Kobalava, A. Konradi, Y. Kotovskaya, M. Kotsani, I....

. 2018 ; 36 (4) : 824-833. [pub] -

Language English Country England, Great Britain

Document type Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't

OBJECTIVE: The aim of the Advanced Approach to Arterial Stiffness study was to compare arterial stiffness measured simultaneously with two different methods in different age groups of middle-aged and older adults with or without metabolic syndrome (MetS). The specific effects of the different MetS components on arterial stiffness were also studied. METHODS: This prospective, multicentre, international study included 2224 patients aged 40 years and older, 1664 with and 560 without MetS. Patients were enrolled in 32 centres from 18 European countries affiliated to the International Society of Vascular Health & Aging. Arterial stiffness was evaluated using the cardio-ankle vascular index (CAVI) and the carotid-femoral pulse wave velocity (CF-PWV) in four prespecified age groups: 40-49, 50-59, 60-74, 75-90 years. In this report, we present the baseline data of this study. RESULTS: Both CF-PWV and CAVI increased with age, with a higher correlation coefficient for CAVI (comparison of coefficients P < 0.001). Age-adjusted and sex-adjusted values of CF-PWV and CAVI were weakly intercorrelated (r = 0.06, P < 0.001). Age-adjusted and sex-adjusted values for CF-PWV but not CAVI were higher in presence of MetS (CF-PWV: 9.57 ± 0.06 vs. 8.65 ± 0.10, P < 0.001; CAVI: 8.34 ± 0.03 vs. 8.29 ± 0.04, P = 0.40; mean ± SEM; MetS vs. no MetS). The absence of an overall effect of MetS on CAVI was related to the heterogeneous effects of the components of MetS on this parameter: CAVI was positively associated with the high glycaemia and high blood pressure components, whereas lacked significant associations with the HDL and triglycerides components while exhibiting a negative association with the overweight component. In contrast, all five MetS components showed positive associations with CF-PWV. CONCLUSION: This large European multicentre study reveals a differential impact of MetS and age on CAVI and CF-PWV and suggests that age may have a more pronounced effect on CAVI, whereas MetS increases CF-PWV but not CAVI. This important finding may be due to heterogeneous effects of MetS components on CAVI. The clinical significance of these original results will be assessed during the longitudinal phase of the study.

1st Department of Cardiology Interventional Electrocardiology and Hypertension Jagiellonian University Medical College Kraków Poland

Almazov Federal Medical Research Centre St Petersburg

Cardiology Centre P Stradins University Hospital Riga Latvia

Cardiovascular Institute Belgrade Serbia

Center for Cardiovascular Prevention Charles University and Thomayer Hospital Prague Czech Republic

Centre of Preventive Cardiology Institute of Cardiology Yerevan Armenia

Clinic of Cardiac and Vascular Diseases Vilnius University University Hospital Santaros Klinikos Vilnius Lithuania

Department of Angiology Cardiometabolic Centre Szent Imre University Teaching Hospital Budapest Hungary

Department of Geriatrics CHRU Nancy University Hospital of Nancy Nancy France

Department of Internal Medicine and Cardiology Hopital 64 RUDN University Moscow

Department of Internal Medicine and Gerontology Jagiellonian University Medical College Kraków Poland

Department of Internal Medicine Hospital Mutua Terrassa University of Barcelona Terrassa Spain

Department of Internal Medicine Medical School National and Kapodistrian University of Athens Athens Greece

Department of Medical Sciences Institut Universitari d'Investigació en Atenció Primària Jordi Gol Barcelona University of Girona Primary Care Services Biomedical Research Institute Institut Català de la Salut Girona Spain

Department of Medicine University of Debrecen Debrecen Hungary

Department of Nephrology Hypertension Dialysis and Transplantation University Hospital Centre Zagreb Croatia

Department of Nutrition and Dietetics School of Health Science and Education Harokopio University Athens Greece

Department of Therapy Ultrasound and Functional Diagnostics Smolensk State Medical Academy Smolensk Russia

Diagnosis and Therapeutic Center Paris Descartes University AP HP Hôtel Dieu Paris

Foundation Medical Research Institutes Paris France

Government Institution L T Malaya Therapy Institute of the National Academy of Medical Sciences of Ukraine Kharkov Ukraine

Inserm U1116 Université de Lorraine

Inserm U1116 Université de Lorraine Department of Geriatrics CHRU Nancy University Hospital of Nancy Nancy France

Inserm U1116 Université de Lorraine Karolinska University Hospital Cardiology Department Stockholm Sweden

Institute of Cardiology Kiev Ukraine

Karolinska University Hospital Cardiology Department Stockholm Sweden

Policlinicio Tor Vergata Universita di Roma Tor Vergata Roma Italy

Primary Healthcare Research Unit La Alamedilla Health Centre Biomedical Research Institute of Salamanca Department of Biomedical and Diagnostic Sciences University of Salamanca Salamanca Spain

Republican Scientific and Practice Centre 'Cardiology' Minsk Belarus

RUDN University Department of Cardiology and Personified Medicine Pirogov Russian National Research Medical University Russian Clinical and Research Centre of Gerontology Moscow Russia

Russian Cardiology Research and Production Complex Moscow

Scientific and Research Institute of Cardiology and Internal Diseases Almaty Kazakhstan

Section of Geriatric Medicine Department of Medicine University of Verona Verona Italy

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19028627
003      
CZ-PrNML
005      
20190823094205.0
007      
ta
008      
190813s2018 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1097/HJH.0000000000001631 $2 doi
035    __
$a (PubMed)29324585
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Topouchian, Jirar $u Diagnosis and Therapeutic Center, Paris-Descartes University, AP-HP, Hôtel Dieu, Paris.
245    10
$a Effects of metabolic syndrome on arterial function in different age groups: the Advanced Approach to Arterial Stiffness study / $c J. Topouchian, C. Labat, S. Gautier, M. Bäck, A. Achimastos, J. Blacher, M. Cwynar, A. de la Sierra, D. Pall, F. Fantin, K. Farkas, L. Garcia-Ortiz, Z. Hakobyan, P. Jankowski, A. Jelakovic, Z. Kobalava, A. Konradi, Y. Kotovskaya, M. Kotsani, I. Lazareva, A. Litvin, V. Milyagin, I. Mintale, O. Persson, R. Ramos, A. Rogoza, L. Ryliskyte, A. Scuteri, Y. Sirenko, G. Soulis, N. Tasic, M. Udovychenko, S. Urazalina, P. Wohlfahrt, P. Zelveian, A. Benetos, R. Asmar,
520    9_
$a OBJECTIVE: The aim of the Advanced Approach to Arterial Stiffness study was to compare arterial stiffness measured simultaneously with two different methods in different age groups of middle-aged and older adults with or without metabolic syndrome (MetS). The specific effects of the different MetS components on arterial stiffness were also studied. METHODS: This prospective, multicentre, international study included 2224 patients aged 40 years and older, 1664 with and 560 without MetS. Patients were enrolled in 32 centres from 18 European countries affiliated to the International Society of Vascular Health & Aging. Arterial stiffness was evaluated using the cardio-ankle vascular index (CAVI) and the carotid-femoral pulse wave velocity (CF-PWV) in four prespecified age groups: 40-49, 50-59, 60-74, 75-90 years. In this report, we present the baseline data of this study. RESULTS: Both CF-PWV and CAVI increased with age, with a higher correlation coefficient for CAVI (comparison of coefficients P < 0.001). Age-adjusted and sex-adjusted values of CF-PWV and CAVI were weakly intercorrelated (r = 0.06, P < 0.001). Age-adjusted and sex-adjusted values for CF-PWV but not CAVI were higher in presence of MetS (CF-PWV: 9.57 ± 0.06 vs. 8.65 ± 0.10, P < 0.001; CAVI: 8.34 ± 0.03 vs. 8.29 ± 0.04, P = 0.40; mean ± SEM; MetS vs. no MetS). The absence of an overall effect of MetS on CAVI was related to the heterogeneous effects of the components of MetS on this parameter: CAVI was positively associated with the high glycaemia and high blood pressure components, whereas lacked significant associations with the HDL and triglycerides components while exhibiting a negative association with the overweight component. In contrast, all five MetS components showed positive associations with CF-PWV. CONCLUSION: This large European multicentre study reveals a differential impact of MetS and age on CAVI and CF-PWV and suggests that age may have a more pronounced effect on CAVI, whereas MetS increases CF-PWV but not CAVI. This important finding may be due to heterogeneous effects of MetS components on CAVI. The clinical significance of these original results will be assessed during the longitudinal phase of the study.
650    _2
$a dospělí $7 D000328
650    _2
$a věkové faktory $7 D000367
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a tlakový index kotník-paže $7 D055109
650    _2
$a arterie $x patofyziologie $7 D001158
650    _2
$a krevní glukóza $x metabolismus $7 D001786
650    _2
$a krevní tlak $7 D001794
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a dyslipidemie $x patofyziologie $7 D050171
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a hyperglykemie $x patofyziologie $7 D006943
650    _2
$a hypertenze $x patofyziologie $7 D006973
650    _2
$a lipoproteiny HDL $x krev $7 D008075
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a metabolický syndrom $x patofyziologie $7 D024821
650    _2
$a lidé středního věku $7 D008875
650    _2
$a obezita $x patofyziologie $7 D009765
650    _2
$a prospektivní studie $7 D011446
650    _2
$a analýza pulzové vlny $7 D063177
650    _2
$a triglyceridy $x krev $7 D014280
650    12
$a tuhost cévní stěny $7 D059289
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Labat, Carlos $u Inserm U1116, Université de Lorraine.
700    1_
$a Gautier, Sylvie $u Department of Geriatrics, CHRU Nancy, University Hospital of Nancy, Nancy, France.
700    1_
$a Bäck, Magnus $u Inserm U1116, Université de Lorraine. Karolinska University Hospital, Cardiology Department, Stockholm, Sweden.
700    1_
$a Achimastos, Apostolos $u Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
700    1_
$a Blacher, Jacques $u Diagnosis and Therapeutic Center, Paris-Descartes University, AP-HP, Hôtel Dieu, Paris.
700    1_
$a Cwynar, Marcin $u Department of Internal Medicine and Gerontology, Jagiellonian University Medical College, Kraków, Poland.
700    1_
$a de la Sierra, Alejandro $u Department of Internal Medicine, Hospital Mutua Terrassa, University of Barcelona, Terrassa, Spain.
700    1_
$a Pall, Denes $u Department of Medicine, University of Debrecen, Debrecen, Hungary.
700    1_
$a Fantin, Francesco $u Section of Geriatric Medicine, Department of Medicine, University of Verona, Verona, Italy.
700    1_
$a Farkas, Katalin $u Department of Angiology, Cardiometabolic Centre, Szent Imre University Teaching Hospital, Budapest, Hungary.
700    1_
$a Garcia-Ortiz, Luis $u Primary Healthcare Research Unit, La Alamedilla Health Centre, Biomedical Research Institute of Salamanca (IBSAL). Department of Biomedical and Diagnostic Sciences, University of Salamanca, Salamanca, Spain.
700    1_
$a Hakobyan, Zoya $u Centre of Preventive Cardiology, Institute of Cardiology, Yerevan, Armenia.
700    1_
$a Jankowski, Piotr $u First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Kraków, Poland.
700    1_
$a Jelakovic, Ana $u Department of Nephrology, Hypertension, Dialysis and Transplantation, University Hospital Centre, Zagreb, Croatia.
700    1_
$a Kobalava, Zhanna $u Department of Internal Medicine and Cardiology, Hopital 64, RUDN University, Moscow.
700    1_
$a Konradi, Alexandra $u Almazov Federal Medical Research Centre, St-Petersburg.
700    1_
$a Kotovskaya, Yulia $u RUDN University. Department of Cardiology and Personified Medicine, Pirogov Russian National Research Medical University. Russian Clinical and Research Centre of Gerontology, Moscow, Russia.
700    1_
$a Kotsani, Marina $u Department of Geriatrics, CHRU Nancy, University Hospital of Nancy, Nancy, France.
700    1_
$a Lazareva, Irina $u Republican Scientific and Practice Centre 'Cardiology', Minsk, Belarus.
700    1_
$a Litvin, Alexander $u Russian Cardiology Research and Production Complex, Moscow.
700    1_
$a Milyagin, Viktor $u Department of Therapy, Ultrasound and Functional Diagnostics, Smolensk State Medical Academy, Smolensk, Russia.
700    1_
$a Mintale, Iveta $u Cardiology Centre, P. Stradins University Hospital, Riga, Latvia.
700    1_
$a Persson, Oscar $u Karolinska University Hospital, Cardiology Department, Stockholm, Sweden.
700    1_
$a Ramos, Rafael $u Department of Medical Sciences, Institut Universitari d'Investigació en Atenció Primària Jordi Gol, Barcelona. University of Girona. Primary Care Services, Biomedical Research Institute, Institut Català de la Salut, Girona, Spain.
700    1_
$a Rogoza, Anatoly $u Russian Cardiology Research and Production Complex, Moscow.
700    1_
$a Ryliskyte, Ligita $u Clinic of Cardiac and Vascular Diseases, Vilnius University, University Hospital Santaros Klinikos, Vilnius, Lithuania.
700    1_
$a Scuteri, Angelo $u Policlinicio Tor Vergata - Universita di Roma Tor Vergata, Roma, Italy.
700    1_
$a Sirenko, Yuriy $u Institute of Cardiology, Kiev, Ukraine.
700    1_
$a Soulis, Georges $u Department of Nutrition and Dietetics, School of Health Science and Education, Harokopio University, Athens, Greece.
700    1_
$a Tasic, Nebojsa $u Cardiovascular Institute, Belgrade, Serbia.
700    1_
$a Udovychenko, Maryna $u Government Institution, L.T. Malaya Therapy Institute of the National Academy of Medical Sciences of Ukraine, Kharkov, Ukraine.
700    1_
$a Urazalina, Saule $u Scientific and Research Institute of Cardiology and Internal Diseases, Almaty, Kazakhstan.
700    1_
$a Wohlfahrt, Peter $u Center for Cardiovascular Prevention, Charles University and Thomayer Hospital, Prague, Czech Republic.
700    1_
$a Zelveian, Parounak $u Centre of Preventive Cardiology, Institute of Cardiology, Yerevan, Armenia.
700    1_
$a Benetos, Athanase $u Inserm U1116, Université de Lorraine. Department of Geriatrics, CHRU Nancy, University Hospital of Nancy, Nancy, France.
700    1_
$a Asmar, Roland $u Foundation-Medical Research Institutes, Paris, France.
773    0_
$w MED00002723 $t Journal of hypertension $x 1473-5598 $g Roč. 36, č. 4 (2018), s. 824-833
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29324585 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20190823094419 $b ABA008
999    __
$a ok $b bmc $g 1433776 $s 1067087
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 36 $c 4 $d 824-833 $e - $i 1473-5598 $m Journal of hypertension $n J Hypertens $x MED00002723
LZP    __
$a Pubmed-20190813

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...